Evidence map›Paper›PMID 39400516›Full record

ReviewPharmacology research & perspectives2024

Nutritional strategies for improving sarcopenia outcomes in older adults: A narrative review.

Beatriz R Goes-Santos, Brian P Carson, Guilherme Wesley Peixoto da Fonseca, Stephan von Haehling

Abstract readReview
In one paragraph

Review in Pharmacology research & perspectives, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Pharmacology and Regulation of Appetite and Food Intake.Pharmacology research & perspectives · 2025
    Article
  11. Review
  12. Development and Validation of a Nomogram Predicting Sarcopenia in Community-Dwelling Older Adults.Inquiry : a journal of medical care organization, provision and financing
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Beatriz R Goes-SantosSchool of Physical Education, State University of Campinas (FEF-UNICAMP), Campinas, São Paulo, Brazil.ORCID 0000-0002-9276-8898
Brian P CarsonDepartment of Physical Education and Sport Sciences, Faculty of Education and Health Sciences, University of Limerick, Limerick, Ireland.ORCID 0000-0001-8350-1481
Guilherme Wesley Peixoto da FonsecaSchool of Physical Education and Sport, University of São Paulo (EEFE-USP), São Paulo, São Paulo, Brazil.ORCID 0000-0001-6477-8741
Stephan von HaehlingDepartment of Cardiology and Pneumology, University of Göttingen Medical Center, Göttingen, Germany.ORCID 0000-0002-9818-042X

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.829284/2023-00
6 · The paper itself

Abstract

Sarcopenia is characterized by a decline in muscle strength, generalized loss of skeletal muscle mass, and impaired physical performance, which are common outcomes used to screen, diagnose, and determine severity of sarcopenia in older adults. These outcomes are associated with poor quality of life, increased risk of falls, hospitalization, and mortality in this population. The development of sarcopenia is underpinned by aging, but other factors can lead to sarcopenia, such as chronic diseases, physical inactivity, inadequate dietary energy intake, and reduced protein intake (nutrition-related sarcopenia), leading to an imbalance between muscle protein synthesis and muscle protein breakdown. Protein digestion and absorption are also modified with age, as well as the reduced capacity of metabolizing protein, hindering older adults from achieving ideal protein consumption (i.e., 1-1.5 g/kg/day). Nutritional supplement strategies, like animal (i.e., whey protein) and plant-based protein, leucine, and creatine have been shown to play a significant role in improving outcomes related to sarcopenia. However, the impact of other supplements (e.g., branched-chain amino acids, isolated amino acids, and omega-3) on sarcopenia and related outcomes remain unclear. This narrative review will discuss the evidence of the impact of these nutritional strategies on sarcopenia outcomes in older adults.

Indexed as

Dietary SupplementsSarcopeniaAgedAged, 80 and overAgingDietary ProteinsHumansMuscle ProteinsMuscle, SkeletalMuscle StrengthQuality of LifeDietary ProteinsMuscle Proteinselderlyleucinemuscle protein synthesisprotein supplementationsarcopenia

Identifiers

PMID39400516
PMCPMC11472304

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.